We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Innovative Coating Relieves Catheter Insertion Pain

By HospiMedica International staff writers
Posted on 18 Mar 2015
A new slippery coating aims to make catheter insertions easier, less painful, and with a reduced risk of inflammation or infection.

Developed by researchers at Queen's University Belfast (QUB; United Kingdom), Uroglide technology is intended for intermittent self-catheterization (ISC) patients who insert and remove disposable catheters themselves between four and eight times per day. The new coating, although cheaper than the current industry standard polyvinyl pyrrolidone (PVP) lubricant, stays wet for longer, is more slippery, and adheres more strongly to the catheter. By easing insertion and removal, it improves the patient’s experience and make a life-changing difference to their dignity and health.

Image: Dr. Nicola Irwin, key scientist for the project, applying Uroglide to a catheter (Photo courtesy of Queen\'s University Belfast).
Image: Dr. Nicola Irwin, key scientist for the project, applying Uroglide to a catheter (Photo courtesy of Queen\'s University Belfast).

Potential benefits of the Uroglide coating include a low coefficient of friction, easy insertion and removal, reduced urethral trauma, enhanced dry-out times (which provide additional time for limited-dexterity users to achieve insertion), improved user satisfaction, and compatibility with standard coating methods. In a range of laboratory tests and human haptic assessments, Uroglide demonstrated a coefficient of friction value up to 40% lower than PVP, and two-fold longer retention of water. Uroglide will be distributed by QUB spinoff Uroglide (Belfast, Ireland), and will become commercially available in 2016.

“For patients with poor control over their bladders, intermittent self-catheterization, which involves the regular insertion of catheters into the bladder via the urethra, has become the norm,” said Prof. Colin McCoy, PhD, of the QUB School of Pharmacy. “Regular insertion of poorly lubricated catheters, however, is painful and can lead to difficult-to-treat urethral complications, such as damage, bleeding, and inflammation. The coatings that are currently used dry out quickly and they've changed very little in over a decade.”

Related Links:

Queen's University Belfast
Uroglide



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Bronchoscope
EB-500

Latest Critical Care News

Machine Learning Tool Identifies Rare, Undiagnosed Immune Disorders from Patient EHRs

On-Skin Wearable Bioelectronic Device Paves Way for Intelligent Implants

First-Of-Its-Kind Dissolvable Stent to Improve Outcomes for Patients with Severe PAD